These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8694559)

  • 21. C-erb-B2 gene amplification and serum level of c-erb-B2 oncoprotein at primary breast cancer diagnosis.
    Fontana X; Ferrari P; Namer M; Peysson R; Salanon C; Bussiere F
    Anticancer Res; 1994; 14(5B):2099-104. PubMed ID: 7840506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-erbB-2 oncoprotein amplification in infiltrating ductal carcinoma of breast relates to high histological grade and loss of oestrogen receptor protein.
    Looi LM; Cheah PL
    Malays J Pathol; 1998 Jun; 20(1):19-23. PubMed ID: 10879259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
    Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical detection of c-erbB-2 oncoprotein in patients with breast cancer.
    Chariyalertsak S; Chariyalertsak S; Cheirsilpa A; Sugano K; Ohkura H
    J Med Assoc Thai; 1996 Nov; 79(11):715-21. PubMed ID: 8997010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic importance of p53 and c-erbB-2 oncoproteins overexpression in patients with breast cancer.
    Chariyalertsak S; Chariyalertsak S; Cheirsilpa A; Chindavijak K
    J Med Assoc Thai; 1998 Sep; 81(9):698-704. PubMed ID: 9737128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective evaluation of CEA and CA 15.3 in patients with locoregional breast cancer.
    Molina R; Filella X; Alicarte J; Zanon G; Pahisa J; Munoz M; Farrus B; Ballesta AM
    Anticancer Res; 2003; 23(2A):1035-41. PubMed ID: 12820344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.
    Meenakshi A; Kumar RS; Kumar NS
    J Immunoassay Immunochem; 2002; 23(3):293-305. PubMed ID: 12227416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.
    Papadopoulou E; Tripsianis G; Anagnostopoulos K; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(2):113-21. PubMed ID: 18237248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serial serum c-erbB-2 levels in patients with breast carcinoma.
    Volas GH; Leitzel K; Teramoto Y; Grossberg H; Demers L; Lipton A
    Cancer; 1996 Jul; 78(2):267-72. PubMed ID: 8674002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of c-erbB-2 and p53 oncoprotein co-overexpression in human breast cancer.
    Barbati A; Cosmi EV; Sidoni A; Collini P; Porpora MG; Ferri I; Lüthy M; Lauro V; Bucciarelli E
    Anticancer Res; 1997; 17(1A):401-5. PubMed ID: 9066684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ; Litman H; Viale G; Maffini F; Masullo M; Golouh R; Martinez-Tello FJ; Grigolato P; Shilkin KB; Gusterson BA; Castiglione-Gertsch M; Price K; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Collins J; Gelber RD; Coates AS; Goldhirsch A;
    Cancer; 2003 Apr; 97(7):1591-600. PubMed ID: 12655514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study.
    Streckfus C; Bigler L; Dellinger T; Dai X; Kingman A; Thigpen JT
    Clin Cancer Res; 2000 Jun; 6(6):2363-70. PubMed ID: 10873088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of osteopontin in patients with triple-negative breast cancer.
    Wang X; Chao L; Ma G; Chen L; Tian B; Zang Y; Sun J
    Eur J Clin Invest; 2008 Jun; 38(6):438-46. PubMed ID: 18452545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. erbB-2 and myc oncoproteins in sera and tumors of breast cancer patients.
    Breuer B; De Vivo I; Luo JC; Smith S; Pincus MR; Tatum AH; Daucher J; Minick CR; Miller DG; Nowak EJ
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):63-6. PubMed ID: 7906981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [C-erbB-2 protein in ovarian epithelial cancer: correlation between expression in tumor tissue and blood levels].
    Felip E; Encabo G; Vidal MT; Vera R; del Campo JM; Rubio D
    Med Clin (Barc); 1995 Jun; 105(1):5-8. PubMed ID: 7637419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.